Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Dificid
Active Ingredient: Fidaxomicin 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Patheon Inc, Ontario, Canada
Product: Erivedge
Active Ingredient: Vismodegib 150mg
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Patheon Inc, Ontario, Canada
Product: Ibugesic
Active Ingredient: Ibuprofen 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Goa, India
Product: Juvederm Hydrate
Active Ingredient: Sodium hyaluronate 13.5mg
Dosage Form: Solution for injection
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan, Pringy, France
Dated this 3rd day of April 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).